Survivin and EPR-1 expression in acute leukemias: Prognostic significance and review of the literature

Leukemia Research

Volumn 31, Issue 11, 2007, Pages 1495-1501

  Oto, Ozgur Akin ^a   Paydas, Semra ^a   Tanriverdi, Kahraman ^b   Seydaoglu, Gulsah ^a   Yavuz, Sinan ^a   Disel, Umut ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute leukemia; EPR 1; Prognosis; Survivin

Indexed keywords

EFFECTOR PROTEASE RECEPTOR 1; SURVIVIN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR;

ACUTE DISEASE; BASE SEQUENCE; DNA PRIMERS; HUMANS; LEUKEMIA; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; PROGNOSIS; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 35448946455     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2007.01.005     Document Type: Article

References (39)

1. Altieri D.C. The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol Med 7 (2001) 542-547
2. Tetsuhisa Y., and Nobuhiko T. The role of survivin as a new target of diagnosis and treatment in human cancer. Med Electron Microsc 34 (2001) 12-20
3. Mahotka C., Wenzel M., Springer E., Gabbert H.E., and Gerharz C.D. Survivin-Ex3 an surviving 2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res 59 (1999) 6097-6102
4. Altieri D.C. Survivin in apoptosis control and cell cycle regulation in cancer. Prog Cell Cycle Res 5 (2003) 447-452
5. Frost M., Jarboe E.A., Orlicky D., Gianani R., Thompson L.C., and Enomoto T. Immunohistochemical localisation of survivin in benign cervical mucosa, cervical dysplasia, and invasive squamous cell carcinoma. Am J Clin Pathol 117 5 (2002) 738-744
6. Altieri D.C., and Marchisio C. Survivin apoptosis: an interloper between cell death and cell proliferation in cancer. Lab Invest 79 11 (1999) 1327-1333
7. Altieri D.C. Xa receptor EPR-1. FASEB J 9 (1995) 860-865
8. Ambrosini G., Adida C., and Sirugo G. Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem 18 (1998) 11177-11182
9. Yamamotoa T., Manomeb Y., Nakamuraa Y., and Tanigawaa N. Downregulation of survivin expression by induction of the effector cell protease receptor-1 reduces tumor growth potential and results in an increased sensitivity to anticancer agents in human colon cancer. Eur J Cancer 38 (2002) 2316-2324
10. Ambrosini G., Adida C., and Altieri D.C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3 (1997) 917-921
11. Asanuma K., Moriai R., Yajima T., Yagihashi A., Yamada M., and Kobayashi D. Survivin as a radioresistance factor in pancreatic cancer. Jpn J Cancer Res 91 (2000) 1204-1209
12. Grossman D., Kim P.J., Schechner J.S., and Altieri D.C. Inhibition of melanoma tumor growth in vivo by survivin targeting. Proc Natl Acad Sci USA 98 (2001) 635-640
13. Smith S.D., Wheeler M.A., Plescia J., Colberg J.W., Weiss R.M., and Altieri D.C. Urine detection of survivin and diagnosis of bladder cancer. JAMA 285 (2001) 324-328
14. Tanaka K., Iwamoto S., Gon G., Nohara T., Iwamoto M., and Tanigawa N. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res 6 (2000) 127-134
15. Ansell S.M., Arendt B.K., Grote D.M., Jelinek D.F., Novak A.J., Wellik L.E., et al. Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin's Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma. Leukemia 18 (2004) 616-623
16. Kappler M., Kotzsch M., Bartel F., and Fussel S. Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival. Clin Cancer Res 9 (2003) 1098-1104
17. Satah K., Kaneko K., Hirota M., Masamune A., Satoh A., and Shimosegawa T. Expression of survivin is correlated with cancer cell apopitosis and is involved in the development of human pancreatic duct cell tumors. Cancer 92 (2001) 271-278
18. Kawasaki H., Altieri D.C., Lu C.D., Toyoda M., Tenjo T., and Tanigawa N. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 58 (1998) 5071-5074
19. Mori N., Yamada Y., Hata T., Ikeda S., Yamasaki Y., Tamanago M., et al. Expression of survivin in HTLV-1 infected T cell lines and primary ATL cells. Biochem Biophys Res Commun 282 (2001) 1110-1113
20. Adida C., Haioun C., Gaulard P., Lepage E., Morel P., Briere J., et al. Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood 96 (2000) 1921-1925
21. Tracey L., Perez-Rosado A., Artiga M.J., Camacho F., Rodriguez A., Martinez N., et al. Expression of the NF KB targets BCL2 and BIRC5/survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively. J Pathol 206 (2005) 123-134
22. Xue Y., Fu-Kun L., Jie-Shou L., Xiao-Ping Q., Bo W., and Hong-Lin Y. Significance of effector protease receptor-1 expression and its relationship with proliferation and apoptotic index in patients with primary advanced gastric adenocarcinoma. World J Gastroenterol 10 (2004) 1262-1267
23. Yoichi W., Kazuhi{dotless}ko K., Soh K., Aki{dotless}hi{dotless}ko T., and Tatsuya A. Effect of survivin on cell proliferation and apoptosis in gastric cancer. Oncol Rep 9 (2002) 1213-1218
24. Shinozawa I., Inokuchi K., Wakabayashi I., and Dan K. Disturbed expression of the anti-apoptosis gene, survivin, and EPR-1 in hematological malignancies. Leuk Res 24 (2000) 965-970
25. Sambrook J., Fritsch E.M., and Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. (1989), Cold Spring Harbor Laboratory, Cold Spring Harbor, New York p. 811-13
26. Pfaffl M.W., and Hageleit M. Validates of mRNA quantification using recombinant RNA and recombinant DNA external calibration curves in real-time RT-PCR. Biotechnol Lett 23 (2001) 275-282
27. Bustin S.A. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assay. J Mol Endocrinol 25 (2000) 169-193
28. Bustin S.A. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J Mol Endocrinol 29 (2002) 23-29
29. Vander Heiden M.G., Chandel N.S., Williamson E.K., Schumacker P.T., and Thompson C.B. Bcl-XL regulates the membrane potential and volume homeostasis of mitochondria. Cell 91 (1997) 627-632
30. Carter B.Z., Mek D.H., Schoder W.D., Cabreire-Hansen M., Beran M., McQueen T., et al. Regulation of survivin expression through Bcr-Abl/MAPK cascade: targeting surviving overcomes imatinib resistance and increases imatinib sensitivity in imatinib-responsive CML cells. Blood 107 (2006) 1555-1563
31. Graaf A.O., van Krieken J.H., Tönnisen E., Wissink W., van de Locht L., Overes I., et al. Expression of C-IAP1, C-IAP2 and survivin discriminates different types of malignancies. Br J Haematol 130 (2005) 852-859
32. Schlette E.J., Medeiros L.J., Goy A., Lai R., and Rassidakis G.Z. Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma. J Clin Oncol 22 (2004) 1682-1688
33. Sugawara M., Matsuzuka F., Fukata S., Kuma K., and Moatamed F. Excessive survivin expression in thyroid lymphomas. Hum Pathol 33 (2002) 524-527
34. Kamihira S., Yamada Y., Hirakata Y., and Tomonaga M. Aberrant expression of caspase cascade regulatory genes in adult T-cell leukaemia: survivin is an important determinant for prognosis. Br J Haematol 114 (2001) 63-69
35. Pizem J., and Cör A. Survivin-an inhibitor of apoptosis and a new therapeutic target in cancer. Radiol Oncol 37 (2003) 195-201
36. Adida C., Recher C., and Raffoux E. Expression and prognostic significance of survivin in de novo acute myeloid leukemia. Br J Haematol 111 (2000) 196-203
37. Paydas S., Tanriverdi K., Yavuz S., Disel U., Sahin B., and Burgut R. Survivin and aven: two distinct antiapoptotic signals in acute leukemias. Ann Oncol 14 (2003) 1045-1050
38. Fields A.C., Cotsonis G., Sexton D., Santoianni R., and Cohen C. Survivin expression in hepatocellular carcinoma: correlation with proliferation, prognostic parameters, and outcome. Mod Pathol 7 (2004) 1378-1385
39. Nakagawa Y., Yamaguchi S., and Hasegawa M. Differential expression of surviving in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia. Leuk Res (2004) 487-494